Clinical applications of glycomic approaches for the detection of cancer and other diseases

Suzanne Miyamoto

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

New glycomic approaches are being developed for clinical applications. Technologies that include microcapillary chromatography, lectin affinity chromatography, carbohydrate microarray and mass spectrometry (MS) enable better glycan analysis and are contributing to drug discovery, clinical assays and basic research efforts. More importantly, new glycomic approaches are contributing to our increased understanding of the underlying biology that is responsible for the development, progression and metastasis of cancer. In fact, disruption of part of the glycosylation process in mice has resulted in higher tumor formation in these animals. MS and lectin affinity methods are rapidly replacing traditional biochemical separation and enzymatic procedures for the analysis of oligosaccharides. These technologies are leading to faster and more clinically adaptable tests with greater sensitivity and specificity than currently used tests. Glycomics is also expected to be important in developing better analytical methods for the detection of cancer. It shows promise for personalized medicine since the heterogeneity and complexity of glycosylation reflect the genetic, environmental, lifestyle and nutritional states of each patient, as well as their ethnicity and age. A major challenge facing glycomics and any systems biology approach, will be the ability to accurately profile the glycosylation state of a patient and, based on this profile, to identify if a disease is present, the type of disease and determine the appropriate treatment for the individual patient. Therefore a comprehensive approach to personalized clinical medicine may include a glycomic analysis of clinical samples and could be used in addition to genetic, gene expression and proteomic analyses already being evaluated for clinical use.

Original languageEnglish (US)
Pages (from-to)507-513
Number of pages7
JournalCurrent Opinion in Molecular Therapeutics
Volume8
Issue number6
StatePublished - Dec 2006

Fingerprint

Glycomics
Glycosylation
Precision Medicine
Neoplasms
Lectins
Mass Spectrometry
Technology
Aptitude
Systems Biology
Clinical Medicine
Drug Discovery
Oligosaccharides
Affinity Chromatography
Proteomics
Polysaccharides
Chromatography
Life Style
Carbohydrates
Neoplasm Metastasis
Gene Expression

Keywords

  • Cancer detection
  • Carbohydrate
  • Glycan
  • Glycoconjugates
  • Glycomics
  • Lectin
  • Microarray
  • MS
  • Oligosaccharide
  • Profiling
  • Serum

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Clinical applications of glycomic approaches for the detection of cancer and other diseases. / Miyamoto, Suzanne.

In: Current Opinion in Molecular Therapeutics, Vol. 8, No. 6, 12.2006, p. 507-513.

Research output: Contribution to journalArticle

@article{eaa2a27cd8544d57bc536986d46a3021,
title = "Clinical applications of glycomic approaches for the detection of cancer and other diseases",
abstract = "New glycomic approaches are being developed for clinical applications. Technologies that include microcapillary chromatography, lectin affinity chromatography, carbohydrate microarray and mass spectrometry (MS) enable better glycan analysis and are contributing to drug discovery, clinical assays and basic research efforts. More importantly, new glycomic approaches are contributing to our increased understanding of the underlying biology that is responsible for the development, progression and metastasis of cancer. In fact, disruption of part of the glycosylation process in mice has resulted in higher tumor formation in these animals. MS and lectin affinity methods are rapidly replacing traditional biochemical separation and enzymatic procedures for the analysis of oligosaccharides. These technologies are leading to faster and more clinically adaptable tests with greater sensitivity and specificity than currently used tests. Glycomics is also expected to be important in developing better analytical methods for the detection of cancer. It shows promise for personalized medicine since the heterogeneity and complexity of glycosylation reflect the genetic, environmental, lifestyle and nutritional states of each patient, as well as their ethnicity and age. A major challenge facing glycomics and any systems biology approach, will be the ability to accurately profile the glycosylation state of a patient and, based on this profile, to identify if a disease is present, the type of disease and determine the appropriate treatment for the individual patient. Therefore a comprehensive approach to personalized clinical medicine may include a glycomic analysis of clinical samples and could be used in addition to genetic, gene expression and proteomic analyses already being evaluated for clinical use.",
keywords = "Cancer detection, Carbohydrate, Glycan, Glycoconjugates, Glycomics, Lectin, Microarray, MS, Oligosaccharide, Profiling, Serum",
author = "Suzanne Miyamoto",
year = "2006",
month = "12",
language = "English (US)",
volume = "8",
pages = "507--513",
journal = "Current Opinion in Molecular Therapeutics",
issn = "1464-8431",
publisher = "Current Drugs Ltd.",
number = "6",

}

TY - JOUR

T1 - Clinical applications of glycomic approaches for the detection of cancer and other diseases

AU - Miyamoto, Suzanne

PY - 2006/12

Y1 - 2006/12

N2 - New glycomic approaches are being developed for clinical applications. Technologies that include microcapillary chromatography, lectin affinity chromatography, carbohydrate microarray and mass spectrometry (MS) enable better glycan analysis and are contributing to drug discovery, clinical assays and basic research efforts. More importantly, new glycomic approaches are contributing to our increased understanding of the underlying biology that is responsible for the development, progression and metastasis of cancer. In fact, disruption of part of the glycosylation process in mice has resulted in higher tumor formation in these animals. MS and lectin affinity methods are rapidly replacing traditional biochemical separation and enzymatic procedures for the analysis of oligosaccharides. These technologies are leading to faster and more clinically adaptable tests with greater sensitivity and specificity than currently used tests. Glycomics is also expected to be important in developing better analytical methods for the detection of cancer. It shows promise for personalized medicine since the heterogeneity and complexity of glycosylation reflect the genetic, environmental, lifestyle and nutritional states of each patient, as well as their ethnicity and age. A major challenge facing glycomics and any systems biology approach, will be the ability to accurately profile the glycosylation state of a patient and, based on this profile, to identify if a disease is present, the type of disease and determine the appropriate treatment for the individual patient. Therefore a comprehensive approach to personalized clinical medicine may include a glycomic analysis of clinical samples and could be used in addition to genetic, gene expression and proteomic analyses already being evaluated for clinical use.

AB - New glycomic approaches are being developed for clinical applications. Technologies that include microcapillary chromatography, lectin affinity chromatography, carbohydrate microarray and mass spectrometry (MS) enable better glycan analysis and are contributing to drug discovery, clinical assays and basic research efforts. More importantly, new glycomic approaches are contributing to our increased understanding of the underlying biology that is responsible for the development, progression and metastasis of cancer. In fact, disruption of part of the glycosylation process in mice has resulted in higher tumor formation in these animals. MS and lectin affinity methods are rapidly replacing traditional biochemical separation and enzymatic procedures for the analysis of oligosaccharides. These technologies are leading to faster and more clinically adaptable tests with greater sensitivity and specificity than currently used tests. Glycomics is also expected to be important in developing better analytical methods for the detection of cancer. It shows promise for personalized medicine since the heterogeneity and complexity of glycosylation reflect the genetic, environmental, lifestyle and nutritional states of each patient, as well as their ethnicity and age. A major challenge facing glycomics and any systems biology approach, will be the ability to accurately profile the glycosylation state of a patient and, based on this profile, to identify if a disease is present, the type of disease and determine the appropriate treatment for the individual patient. Therefore a comprehensive approach to personalized clinical medicine may include a glycomic analysis of clinical samples and could be used in addition to genetic, gene expression and proteomic analyses already being evaluated for clinical use.

KW - Cancer detection

KW - Carbohydrate

KW - Glycan

KW - Glycoconjugates

KW - Glycomics

KW - Lectin

KW - Microarray

KW - MS

KW - Oligosaccharide

KW - Profiling

KW - Serum

UR - http://www.scopus.com/inward/record.url?scp=33845528552&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845528552&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 507

EP - 513

JO - Current Opinion in Molecular Therapeutics

JF - Current Opinion in Molecular Therapeutics

SN - 1464-8431

IS - 6

ER -